Wednesday, October 22, 2025 – Main Conference Day 2Wednesday, 22 October 2025 - JT (Japan Time, GMT+09:00)

The Genedata E2E Platform, also known as Genedata Bioprocess®, is designed to unify fragmented digital ecosystems in bioprocess development by integrating data from ELNs, LIMS, and data lakes to streamline decision-making and process analytical technology (PAT) implementation. The platform manages all stages of bioprocessing, including upstream and downstream processing, formulation, and cell line development, enabling organizations to design advanced workflows, select high-yield cell lines, and optimize media and scale-up processes. Additionally, integration with robotics and automation supports high-throughput operations, while built-in data integrity and compliance features ensure product quality, safety, and regulatory readiness.

Genedata Bioprocess® enables structured CMC data capture, efficient analysis, and seamless transfer to regulatory agencies. Supports all biotherapeutic modalities, it provides unique identifiers, genealogy tracking, and robust quality control. Applying automation to data capture, analysis, and reporting accelerates workflows, while AI/ML integration enables advanced analytics and predictive modeling. Real-world applications have demonstrated significant reductions in analysis time and improved data-driven decision-making. This unified approach empowers biopharma organizations to develop innovative biotherapeutics and novel modalities more efficiently, ensuring compliance and fostering rapid innovation.